Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 3 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar pchop123 (79.57) Submitted: 1/8/2013 12:02:50 PM : Underperform Start Price: $2.29 ACUR Score: +7.09

Little to be optomistic about with this bird

Featured Broker Partners


Advertisement